Next Article in Journal
Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
Previous Article in Journal
Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin

by
Miroslav RADENKOVIĆ
*,
Marko STOJANOVIĆ
,
Nebojša SKORUPAN
and
Milica PROSTRAN
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(3), 749-762; https://doi.org/10.3797/scipharm.1305-13
Submission received: 7 May 2013 / Accepted: 4 June 2013 / Published: 4 June 2013

Abstract

Bradykinin (BK) plays an important role in different physiological processes including the general preservation and modulation of vascular systems. The present study was designed in order to examine the effect of BK on isolated rat femoral artery rings and to investigate the participation of intact endothelium, cyclooxygenase products, Ca2+ channels, Na+/K+–ATPase, and B2 kinin receptors in BK-induced action. Circular artery segments were placed in organ baths. The endothelium was mechanically removed from some arteries. Concentration–contraction curves for BK were obtained in the rings previously equilibrated at the basal tone. BK produced a concentration–dependent contraction, which was reduced by endothelial denudation. The BK–induced effect was almost completely inhibited by indomethacin (cyclooxygenase inhibitor) or OKY–046 (thromboxane A2–synthase inhibitor). Nifedipine (Ca2+ channel blocker), ouabain (Na+/K+–ATPase inhibitor), or HOE–140 (selective B2 kinin receptor antagonist) significantly reduced the BK–evoked effect. In conclusion, it can be proposed that BK produces concentration– and endothelium–dependent contractions of the isolated rat femoral artery, which is for the most part a consequence of B2 kinin receptor activation. Cyclooxygenase contractile products, especially thromboxane A2, play a significant role in this course of action. The transduction mechanism involved in the process of BK–induced femoral artery contraction include the activation of voltage–gated Ca2+ channels, and in a smaller extent Na+/K+–ATPase as well.
Keywords: Bradykinin; Femoral artery; Endothelium; Ca2+ channels; Thromboxane A2Introduction Bradykinin; Femoral artery; Endothelium; Ca2+ channels; Thromboxane A2Introduction

Share and Cite

MDPI and ACS Style

RADENKOVIĆ, M.; STOJANOVIĆ, M.; SKORUPAN, N.; PROSTRAN, M. Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin. Sci. Pharm. 2013, 81, 749-762. https://doi.org/10.3797/scipharm.1305-13

AMA Style

RADENKOVIĆ M, STOJANOVIĆ M, SKORUPAN N, PROSTRAN M. Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin. Scientia Pharmaceutica. 2013; 81(3):749-762. https://doi.org/10.3797/scipharm.1305-13

Chicago/Turabian Style

RADENKOVIĆ, Miroslav, Marko STOJANOVIĆ, Nebojša SKORUPAN, and Milica PROSTRAN. 2013. "Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin" Scientia Pharmaceutica 81, no. 3: 749-762. https://doi.org/10.3797/scipharm.1305-13

Article Metrics

Back to TopTop